SCHEDULE 13D

Company

RIGEL PHARMACEUTICALS INC

Filed

May 14, 2003

Accession Number

0000950149-03-001161

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →